A total of 15 patients, who had X-linked severe combined immunodeficiency (X-SCID) post-hematopoietic stem cell transplant (HSCT) (n=1), STAT1 gain-of-function (n=1), severe congenital neutropenia (SCN, n=1), ataxia telangiectasia (n=1), and humoral immunodeficiencies (n=11), did not respond and were seronegative after 2 doses, suggesting these IEIs were associated with seroconversion failure (Figure 2A). This evidence concerns the gene STAT1 and ataxia telangiectasia.